We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$18.6M
Cap. Flow
+$5.56M
Cap. Flow %
1.53%
Top 10 Hldgs %
25.94%
Holding
173
New
49
Increased
12
Reduced
23
Closed
40

Top Buys

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$20.1M
2
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.18M
3
CBAY
Cymabay Therapeutics
CBAY
+$6.64M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$6.41M
5
QDEL icon
QuidelOrtho
QDEL
+$5.15M

Top Sells

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$7.59M
2
ARQT icon
Arcutis Biotherapeutics
ARQT
+$6.09M
3
CDNA icon
CareDx
CDNA
+$5.7M
4
HAE icon
Haemonetics
HAE
+$5.22M
5
LITS
Lite Strategy Inc
LITS
+$5.04M

Sector Composition

Rank Sector Weight
1 Healthcare 79.63%
2 Financials 7.92%
3 Technology 1.93%
4 Industrials 1.24%
5 Communication Services 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRSAW
126
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$71K 0.02%
75,000
– –
RSVRW
127
DELISTED
Reservoir Media Inc Warrant
RSVRW
$70K 0.02%
50,000
– –
TMPMW
128
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$51K 0.01%
84,666
– –
AXH.WS
129
DELISTED
Industrial Human Capital, Inc. Warrants
AXH.WS
$38K 0.01%
+100,000
New +$40.1K
GIWWW
130
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$29K 0.01%
50,000
– –
MITAW
131
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$23K 0.01%
+28,333
New +$21.4K
PSQH.WS icon
132
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$9K ﹤0.01%
16,666
– –
UPH.WS
133
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$3K ﹤0.01%
10,000
– –
AFMD
134
DELISTED
Affimed
AFMD
– –
-66,500
Closed -$4.11M
ALDX icon
135
Aldeyra Therapeutics
ALDX
$93.5M
– –
-864,020
Closed -$7.59M
ALGS icon
136
Aligos Therapeutics
ALGS
$34.6M
– –
-1,340
Closed -$519K
APLS
137
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-166,700
Closed -$5.49M
ARCT icon
138
Arcturus Therapeutics
ARCT
$211M
– –
-80,000
Closed -$3.82M
ARQT icon
139
Arcutis Biotherapeutics
ARQT
$3.18B
– –
-255,000
Closed -$6.09M
AUPH icon
140
Aurinia Pharmaceuticals
AUPH
$2.04B
– –
-144,000
Closed -$3.19M
BBIO icon
141
BridgeBio Pharma
BBIO
$16.5B
– –
-79,000
Closed -$3.34M
CDNA icon
142
CareDx
CDNA
$2.42B
– –
-90,000
Closed -$5.7M
CSTL icon
143
Castle Biosciences
CSTL
$979M
– –
-72,500
Closed -$4.82M
HAE icon
144
Haemonetics
HAE
$4B
– –
-74,000
Closed -$5.22M
IGMS
145
DELISTED
IGM Biosciences
IGMS
– –
-42,473
Closed -$2.79M
KRYS icon
146
CALL
Krystal Biotech
KRYS
$9.66B
– –
-5,800
Closed -$303K
LFMD icon
147
LifeMD
LFMD
$172M
– –
-288,700
Closed -$1.79M
LITS
148
Lite Strategy Inc
LITS
$30.9M
– –
-91,403
Closed -$5.04M
MREO
149
Mereo BioPharma
MREO
$47.3M
– –
-1,250,000
Closed -$3.02M
PODD icon
150
Insulet
PODD
$9.79B
– –
-4,250
Closed -$1.21M
3 4 5
6
7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Altium Capital Management held 173 positions worth $363M, down 4.9% from $381M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Altium Capital Management's Q4 2021 filing shows 49 new, 12 increased, 23 reduced and 40 closed positions. Its largest new stake was Esperion Therapeutics: 2,515,785 shares worth $12.6M. The largest sale was Aldeyra Therapeutics, an estimated $7.59M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 82% a quarter earlier, followed by Financials and Technology.

  • Altium Capital Management's largest Q4 2021 buy was Esperion Therapeutics: 2,515,785 shares worth $12.6M.
  • Altium Capital Management added most to Bicycle Therapeutics in Q4 2021, an estimated $4.41M increase.
  • Altium Capital Management's biggest Q4 2021 reduction was Cerus, cutting an estimated $4.27M.
  • Altium Capital Management fully exited Aldeyra Therapeutics in Q4 2021, selling an estimated $7.59M.
  • Altium Capital Management's ten largest holdings make up 26% of its $363M portfolio in Q4 2021.
  • Altium Capital Management opened 49 new positions and closed 40 in Q4 2021.
  • Altium Capital Management's portfolio value fell 4.9% quarter-over-quarter to $363M.

Based on Altium Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.